Schoentgen Nadja, Califano Gianluigi, Manfredi Celeste, Romero-Otero Javier, Chun Felix K H, Ouzaid Idir, Hermieu Jean-François, Xylinas Evanguelos, Verze Paolo
Department of Urology, Bichat Claude Bernard Hospital, Paris, France.
Department of Neurosciences, Reproductive Sciences, Odontostomatology, University of Naples Federico II, Naples, Italy.
Front Surg. 2021 Apr 21;8:648345. doi: 10.3389/fsurg.2021.648345. eCollection 2021.
Sexual dysfunction (SD) is a frequent side effect associated with radical prostatectomy (RP) for prostate cancer (PCa). Some studies have showed the benefit associated with preoperative sexual rehabilitation (prehabilitation) and Enhanced Recovery After Surgery (ERAS) for RP, but no clear clinical recommendations are available yet. Our aim was to conduct a systematic review on sexual prehabilitation prior to RP for patients with a localized PCa and analyze the impact on postoperative sexual health compared with the standard post-operative care. We performed a systematic review of the literature following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) recommendations. Four randomized control trials and one retrospective comparative study were included in the analyses. Three of the five studies showed an improved EF recovery post-RP in the prehabilitation group compared to the standard of care represented by: higher International Index of Erectile Function 5 score (IIEF5) or IIEF score ( < 0.0001) and a higher percentage of patients reporting return of EF based on the Sexual Encounter Profile (SEP) (56 vs. 24%, = 0.007). Self-confidence, therapeutic alliance, and adherence to treatment were stronger for patients with preoperative consultations ( < 0.05) and EF recovery was better in cases of a higher number of follow-up visits (OR 4-5 visits vs. 1:12.19, = 0.002). Despite heterogenous methods and high risks of bias in this systematic review, starting sexual rehabilitation prior to surgery seems to ensure better EF recovery. This prehabilitation should include information of both the patient and his or her partner, with a closer follow up and the use of a multimodal treatment approach that still remains to be defined and validated (oral medication, vacuum devices, pelvic floor muscle training, etc.).
性功能障碍(SD)是前列腺癌(PCa)根治性前列腺切除术(RP)常见的副作用。一些研究显示了术前性康复(预康复)和RP术后加速康复(ERAS)的益处,但目前尚无明确的临床建议。我们的目的是对局限性PCa患者RP术前的性预康复进行系统评价,并分析与标准术后护理相比,其对术后性健康的影响。我们按照系统评价和Meta分析的首选报告项目(PRISMA)建议对文献进行了系统评价。分析纳入了四项随机对照试验和一项回顾性比较研究。五项研究中的三项显示,与以以下为代表的标准护理相比,预康复组RP术后勃起功能(EF)恢复有所改善:国际勃起功能指数5评分(IIEF5)或IIEF评分更高(<0.0001),以及根据性经历概况(SEP)报告EF恢复的患者比例更高(56%对24%,P=0.007)。术前咨询的患者自信心、治疗联盟和治疗依从性更强(<0.05),随访次数较多的患者EF恢复更好(OR 4 - 5次随访对1次:12.19,P=0.002)。尽管本系统评价方法存在异质性且偏倚风险高,但术前开始性康复似乎可确保更好的EF恢复。这种预康复应包括患者及其伴侣的信息,密切随访,并采用仍有待定义和验证的多模式治疗方法(口服药物、真空装置、盆底肌肉训练等)。